Ahmed O. Kaseb

The University of Texas MD Anderson Cancer Center

Also affiliated with Scripps MD Anderson Cancer Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.7Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation

Scientific Data(2023)10.1038/s41597-023-01928-3

Top 12%

1.7DataRank

Top 12%47 citations

Ali Morshid, Ahmed Khalaf, Mohab M. Elmohr, John D. Hazle, David Fuentes +12 more

Papers

Driven by 43 papers — median percentile 88. Top paper: “Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial”.

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: a randomised, open-label, phase 2 trial

The Lancet. Gastroenterology & hepatology(2022)10.1016/s2468-1253(21)00427-1

N/A

4.7DataRank · unranked

263 citations

Elshad Hasanov, Hop Sanderson Tran Cao, Lianchun Xiao, Jean‐Nicolas Vauthey, Sunyoung S. Lee +24 more

Multimodality annotated hepatocellular carcinoma data set including pre- and post-TACE with imaging segmentation

Scientific Data(2023)10.1038/s41597-023-01928-3

Top 12%

1.7DataRank

Top 12%47 citations

Ali Morshid, Ahmed Khalaf, Mohab M. Elmohr, John D. Hazle, David Fuentes +12 more

Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma

New England Journal of Medicine(2020)10.1056/nejmoa1915745

N/A

1.3DataRank · unranked

7029 citations

Shukui Qin, Masafumi Ikeda, Peter R. Galle, Michel Ducreux, Tae-You Kim +19 more

Software-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomised phase 2 trial

The Lancet. Gastroenterology & hepatology(2025)10.1016/s2468-1253(25)00024-x

N/A

1.0DataRank · unranked

51 citations

Jessica Albuquerque, Yuan‐Mao Lin, Brian Anderson, Caleb S O'Connor, B. Rigaud +25 more

Phase I Trial of TTI-101, a First-in-Class Oral Inhibitor of STAT3, in Patients with Advanced Solid Tumors

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-2920

N/A

0.977DataRank · unranked

49 citations

David Vining, Sukeshi Patel Arora, Sofia de Achaval, Jeffrey Larson, John Kauh +6 more

Phase I trial of single-photon emission computed tomography–guided liver-directed radiotherapy for patients with low functional liver volume

JNCI Cancer Spectrum(2024)10.1093/jncics/pkae037

N/A

0.340DataRank · unranked

6 citations

Franklin C. Wong, Beth Chasen, William D. Erwin, Prajnan Das, Emma B. Holliday +27 more

Fixed-Dose Netupitant and Palonosetron for Chronic Nausea in Cancer Patients: A Double-Blind, Placebo Run-in Pilot Randomized Clinical Trial

Journal of Pain and Symptom Management(2020)10.1016/j.jpainsymman.2020.12.023

N/A

0.292DataRank · unranked

6 citations

Veronica Puac, Zeena Shelal, Diane Liu, Rama Maddi, Ahmed O. Kaseb +6 more

Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib

Oncotarget(2021)10.18632/oncotarget.27924

N/A

0DataRank · unranked

3 citations

Sunyoung Lee, Lianchun Xiao, Manal M. Hassan, Aliya Qayyum, Rikita Hiatia +12 more

Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma

Cancers(2022)10.3390/cancers14081901

N/A

0DataRank · unranked

34 citations

Brian De, Chike O. Abana, Sunyoung S. Lee, Milind Javle, Ahmed O. Kaseb +10 more

Blockade of growth hormone receptor signaling by using pegvisomant: A functional therapeutic strategy in hepatocellular carcinoma

Frontiers in Oncology(2022)10.3389/fonc.2022.986305

N/A

0DataRank · unranked

24 citations

Abedul Haque, Deeksha Vishwamitra, Manal M. Hassan, Lianchun Xiao, Bhawana George +11 more

Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development

Journal of Hepatocellular Carcinoma(2022)10.2147/jhc.s368208

N/A

0DataRank · unranked

23 citations

Vishal Sahu, Jamie Lombardo, Lianchun Xiao, Bhawana George, Robert A. Wolff +6 more

Plasma growth hormone is a potential biomarker of response to atezolizumab and bevacizumab in advanced hepatocellular carcinoma patients

Oncotarget(2022)10.18632/oncotarget.28322

N/A

0DataRank · unranked

17 citations

Dan G. Duda, Muhammad O. Awiwi, Sunyoung S. Lee, Lina Altameemi, Lianchun Xiao +13 more

Immune modulation by molecularly targeted photothermal ablation in a mouse model of advanced hepatocellular carcinoma and cirrhosis

Scientific Reports(2022)10.1038/s41598-022-15948-3

N/A

0DataRank · unranked

14 citations

Crystal Dupuis, Malea Williams, K. Dixon, Amanda McWatters, Jie Zhang +6 more

Two distinct stem cell‐like subtypes of hepatocellular carcinoma with clinical significance and their therapeutic potentials

Cancer Communications(2022)10.1002/cac2.12251

N/A

0DataRank · unranked

7 citations

Yun Seong Jeong, Sunyoung Lee, Bo Hwa Sohn, Ho Kyoung Hwang, Gi Hong Choi +11 more

Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells

Proceedings of the National Academy of Sciences(2023)10.1073/pnas.2300706120

N/A

0DataRank · unranked

46 citations

Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T. Ryujin, Jian Yu Huang +8 more

Efficacy and safety of atezolizumab/bevacizumab in patients with HCC after prior systemic therapy: A global, observational study

Hepatology Communications(2023)10.1097/hc9.0000000000000302

N/A

0DataRank · unranked

11 citations

Bernhard Scheiner, Antonio D ́Alessio, Claudia Angela Maria Fulgenzi, Martin Schönlein, Lorenz Kocheise +31 more

Prevention of Hepatocellular Carcinoma (HCC). White Paper of the Texas Collaborative Center for Hepatocellular Cancer (TeCH) Multi-stakeholder Conference

Clinical Gastroenterology and Hepatology(2023)10.1016/j.cgh.2023.03.029

N/A

0DataRank · unranked

8 citations

John W. Ward, Sumeet K. Asrani, Amit G. Singal, Nicole E. Rich, Aaron P. Thrift +7 more

Development of a Novel Comprehensive Hepatocellular Carcinoma Outcome Prognostic Scoring System With Integration of Imaging Features

The Oncologist(2023)10.1093/oncolo/oyad329

N/A

0DataRank · unranked

1 citations

Russell G. Witt, Khaled M. Elsayes, Ali Baiomy, Lianchun Xiao, Sarah Palmquist +14 more

Phase 1 trial evaluating TTI-101, a first-in-class, orally bioavailable, small molecule, inhibitor of STAT3, in patients with advanced solid tumors.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.3018

N/A

0DataRank · unranked

15 citations

David Vining, Sukeshi Patel Arora, Sofia de Achaval, Jeffrey Larson, Carrie Cartwright +4 more

Angiotensin II receptor inhibition ameliorates liver fibrosis and enhances hepatocellular carcinoma infiltration by effector T cells

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.03.05.531188

N/A

0DataRank · unranked

5 citations

Yahui Zhu, Maiya Lee, Albert Nguyen, Nicolas T. Ryujin, Jian Yu Huang +7 more

Genome-wide association study identifies high-impact susceptibility loci for HCC in North America

Hepatology(2024)10.1097/hep.0000000000000800

N/A

0DataRank · unranked

39 citations

Donghui Li, Younghun Han, Jinyoung Byun, Rikita Hatia, Erping Long +48 more

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer

Molecular Cancer(2024)10.1186/s12943-024-02060-5

N/A

0DataRank · unranked

24 citations

Vrushaly Shinglot, Javier Ruiz-Ramírez, Joseph Cave, Joseph D. Butner, Carmine Schiavone +9 more

Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial

Clinical and Molecular Hepatology(2024)10.3350/cmh.2024.0333

N/A

0DataRank · unranked

23 citations

Sung Hwan Lee, Seung-Woo Baek, Bohwa Sohn, Yun Seong Jeong, Sang-Hee Kang +10 more

Circulating tumor DNA (ctDNA) as a biomarker of response to therapy in advanced Hepatocellular carcinoma treated with Nivolumab

Cancer Biomarkers(2024)10.3233/cbm-230431

N/A

0DataRank · unranked

12 citations

Sunyoung S. Lee, Tarık Demir, Shadi Chamseddine, Zishuo Ian Hu, Lianchun Xiao +17 more

Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular Carcinoma

Journal of Immunotherapy and Precision Oncology(2024)10.36401/jipo-24-6

N/A

0DataRank · unranked

8 citations

Betül Gök Yavuz, Yehia I. Mohamed, Sunyoung S. Lee, James C. Yao, Zishuo Ian Hu +13 more

Plasma Growth Hormone as a Prognostic Biomarker to Durvalumab and Tremelimumab in Patients with Advanced Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma(2024)10.2147/jhc.s452564

N/A

0DataRank · unranked

2 citations

Michael LaPelusa, Lianchun Xiao, Yehia I. Mohamed, Sunyoung Lee, Zishuo Hu +8 more

Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response

medRxiv(2024)10.1101/2024.09.11.24313334

N/A

0DataRank · unranked

5 citations

Prashant Dogra, Mohamed Zaid, Dalia Elganainy, Kevin Sun, Ahmed Amer +26 more

Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer

medRxiv(2024)10.1101/2024.03.14.24304306

N/A

0DataRank · unranked

2 citations

Vrushaly Shinglot, Javier Ruiz-Ramírez, Joseph Cave, Joseph D. Butner, Carmine Schiavone +9 more

Correspondence to editorial 1 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial”

Clinical and Molecular Hepatology(2024)10.3350/cmh.2024.0829

N/A

0DataRank · unranked

1 citations

Sun Young Yim, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Ju‐Seog Lee +1 more

Correspondence to letter to the editor on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”

Clinical and Molecular Hepatology(2024)10.3350/cmh.2024.0828

N/A

0DataRank · unranked

0 citations

Sun Young Yim, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Peng Wei +2 more

Correspondence to editorial 2 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 trial”

Clinical and Molecular Hepatology(2024)10.3350/cmh.2024.0830

N/A

0DataRank · unranked

0 citations

Sung-Hwan Lee, Ji Hoon Kim, Sunyoung S. Lee, Ahmed O. Kaseb, Ju‐Seog Lee +1 more

Reproducible safety and efficacy of durvalumab with or without tremelimumab for hepatocellular carcinoma in clinical practice: Results of the DT-real study

JHEP Reports(2025)10.1016/j.jhepr.2025.101685

N/A

0DataRank · unranked

2 citations

Tiziana Pressiani, Naoshi Nishida, Shadi Chamseddine, Ashwini Arvind, Michael Li +36 more

Access to Medical Research is a Basic Human Right: A Roadmap to Research Integration Into a Practical Hepatocellular Carcinoma Treatment Allocation Algorithm (HCC-TAA)

Journal of Hepatocellular Carcinoma(2025)10.2147/jhc.s523470

N/A

0DataRank · unranked

1 citations

Ahmed O. Kaseb

Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits

International Journal of Cancer(2025)10.1002/ijc.70136

N/A

0DataRank · unranked

1 citations

Vikram R. Shaw, Jinyoung Byun, Aaron P. Thrift, Catherine Zhu, Donghui Li +33 more

Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus

Journal of Hepatocellular Carcinoma(2025)10.2147/jhc.s477141

N/A

0DataRank · unranked

1 citations

Lu-Yu Hwang, Ruosha Li, Catherine Troisi, Prasun K. Jalal, Christopher I. Amos +7 more

Evaluating the role of preoperative serum insulin-like growth factor 1 as a predictor of survival and recurrence for patients with resectable hepatocellular carcinoma

Journal of Gastrointestinal Surgery(2025)10.1016/j.gassur.2025.102275

N/A

0DataRank · unranked

0 citations

Antony Haddad, Manal M. Hassan, Hesham M. Amin, Timothy E. Newhook, Yun Shin Chun +5 more

Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response

npj Systems Biology and Applications(2025)10.1038/s41540-025-00616-9

N/A

0DataRank · unranked

0 citations

Prashant Dogra, Mohamed Zaid, Dalia Elganainy, Kevin Sun, Ahmed Amer +26 more

Molecularly targeted photothermal ablation improves tumor specificity and immune modulation in a rat model of hepatocellular carcinoma

Communications Biology(2020)10.1038/s42003-020-01522-y

N/A

0DataRank · unranked

18 citations

Crystal Dupuis, Malea Williams, K. Dixon, Amanda McWatters, Rony Avritscher +6 more

IGF-Child-Turcotte-Pugh score as a predictor of treatment outcome in Child-Pugh A, advanced hepatocellular carcinoma patients undergoing sorafenib therapy.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e16660

N/A

0DataRank · unranked

1 citations

Aliya Qayyum, Manal M. Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia +9 more

IGF-1 Child-Turcotte-Pugh score as a predictor of overall survival to therapy in CTP-A, BCLC stage C patients with advanced hepatocellular carcinoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.4_suppl.488

N/A

0DataRank · unranked

0 citations

Aliya Qayyum, Manal M. Hassan, Lianchun Xiao, Dan G. Duda, Rikita Hatia +8 more

Phase 1 trial of ADI-PEG20 plus cisplatin in patients with pretreated metastatic melanoma or other advanced solid malignancies

British Journal of Cancer(2021)10.1038/s41416-020-01230-8

N/A

0DataRank · unranked

43 citations

Filip Jankú, Vivek Subbiah, John Stewart, Sapna P. Patel, Ahmed O. Kaseb +10 more

Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy

Journal of Hepatocellular Carcinoma(2021)10.2147/jhc.s282062

N/A

0DataRank · unranked

47 citations

Sweet Ping Ng, Amy Liu, Santiago Avila, Randa Tao, Emma B. Holliday +19 more

Association of dietary fat intake and hepatocellular carcinoma among US adults

Cancer Medicine(2021)10.1002/cam4.4256

N/A

0DataRank · unranked

19 citations

R. Sue Day, Ruosha Li, Ahmed O. Kaseb, Prasun K. Jalal, Carrie R. Daniel +7 more

Ahmed O. Kaseb

Indexed papers

Top data-sharing exemplar

Papers